Lactose India [LACTOSE] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Lactose India Ltd. wins in 7 metrics, Divi's Laboratories Ltd. wins in 12 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lactose India Ltd. | Divi's Laboratories Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 30.45 | 67.11 | Lactose India Ltd. |
| Price-to-Book Ratio | 2.38 | 10.82 | Lactose India Ltd. |
| Debt-to-Equity Ratio | 86.78 | 0.58 | Divi's Laboratories Ltd. |
| PEG Ratio | 0.21 | 4.63 | Lactose India Ltd. |
| EV/EBITDA | 12.54 | 48.63 | Lactose India Ltd. |
| Profit Margin (TTM) | 3.32% | 24.04% | Divi's Laboratories Ltd. |
| Operating Margin (TTM) | 4.45% | 29.65% | Divi's Laboratories Ltd. |
| EBITDA Margin (TTM) | 4.45% | 29.65% | Divi's Laboratories Ltd. |
| Return on Equity | 8.79% | 14.64% | Divi's Laboratories Ltd. |
| Return on Assets (TTM) | 3.87% | 12.94% | Divi's Laboratories Ltd. |
| Free Cash Flow (TTM) | $-146.70M | $2.15B | Divi's Laboratories Ltd. |
| Dividend Yield | N/A | 0.91% | N/A |
| 1-Year Return | 20.41% | 0.83% | Lactose India Ltd. |
| Price-to-Sales Ratio (TTM) | 1.02 | 16.18 | Lactose India Ltd. |
| Enterprise Value | $1.98B | $1,635.46B | Divi's Laboratories Ltd. |
| EV/Revenue Ratio | 1.36 | 15.86 | Lactose India Ltd. |
| Gross Profit Margin (TTM) | 27.83% | 63.71% | Divi's Laboratories Ltd. |
| Revenue per Share (TTM) | $118 | $388 | Divi's Laboratories Ltd. |
| Earnings per Share (Diluted) | $3.86 | $93.66 | Divi's Laboratories Ltd. |
| Beta (Stock Volatility) | 0.39 | 0.19 | Divi's Laboratories Ltd. |
Lactose India Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lactose India Ltd. | 5.86% | -6.31% | -3.48% | 17.55% | -7.12% | 3.88% |
| Divi's Laboratories Ltd. | 0.67% | -3.26% | -1.31% | 2.02% | 1.80% | 2.98% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lactose India Ltd. | 20.41% | 127.85% | 280.87% | 63.03% | 1,621.05% | 19,298.31% |
| Divi's Laboratories Ltd. | 0.83% | 89.86% | 56.44% | 484.44% | 1,625.50% | 9,907.51% |
Performance & Financial Health Analysis: Lactose India Ltd. vs Divi's Laboratories Ltd.
| Metric | LACTOSE | DIVISLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.48B | ₹1.69T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 9,346 | 253,443 |
| 90 Day Avg. Volume | 7,204 | 283,911 |
| Last Close | ₹114.65 | ₹6,576.50 |
| 52 Week Range | ₹76.01 - ₹136.70 | ₹5,636.50 - ₹7,071.50 |
| % from 52W High | -16.13% | -7.00% |
| All-Time High | ₹247.40 (Dec 09, 2024) | ₹7,071.50 (Jul 08, 2025) |
| % from All-Time High | -53.66% | -7.00% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.28% | 0.12% |
| Quarterly Earnings Growth | 1.42% | -0.01% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.24% |
| Operating Margin (TTM) | 0.04% | 0.30% |
| Return on Equity (TTM) | 0.09% | 0.15% |
| Debt to Equity (MRQ) | 86.78 | 0.58 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹49.43 | ₹580.95 |
| Cash per Share (MRQ) | ₹3.25 | ₹122.95 |
| Operating Cash Flow (TTM) | ₹-49,118,000 | ₹19.67B |
| Levered Free Cash Flow (TTM) | ₹51.63M | ₹21.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.91% |
| Last 12-Month Dividend | N/A | ₹60.00 |
Valuation & Enterprise Metrics Analysis: Lactose India Ltd. vs Divi's Laboratories Ltd.
| Metric | LACTOSE (Apr 24, 2026) | DIVISLAB (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 30.45 | 67.11 |
| Forward P/E | N/A | 53.75 |
| PEG Ratio | 0.21 | 4.63 |
| Price to Sales (TTM) | 1.02 | 16.18 |
| Price to Book (MRQ) | 2.38 | 10.82 |
| Market Capitalization | ||
| Market Capitalization | ₹1.48B | ₹1.69T |
| Enterprise Value | ₹1.98B | ₹1.64T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.36 | 15.86 |
| Enterprise to EBITDA | 12.54 | 48.63 |
| Risk & Other Metrics | ||
| Beta | 0.39 | 0.19 |
| Book Value per Share (MRQ) | ₹49.43 | ₹580.95 |
Financial Statements Comparison: Lactose India Ltd. vs Divi's Laboratories Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | LACTOSE (2025) | DIVISLAB (2025) |
|---|---|---|
| Revenue/Sales | 1.16B | 93.25B |
| Cost of Goods Sold | 772.10M | 38.70B |
| COGS % of Revenue | 66.4% | 41.5% |
| Gross Profit | 390.56M | 54.55B |
| Gross Margin | 33.6% | 58.5% |
| Research & Development | N/A | 270.00M |
| Operating Income (EBIT) | 115.95M | 25.71B |
| Operating Margin | 10.0% | 27.6% |
| EBITDA | 175.41M | 33.19B |
| EBITDA Margin | 15.1% | 35.6% |
| Pre-Tax Income | 69.18M | 29.16B |
| Pre-Tax Income % of Revenue | 5.9% | 31.3% |
| Income Tax | 17.55M | 7.25B |
| Income Tax % of Revenue | 1.5% | 7.8% |
| Net Income (Profit) | 51.63M | 21.91B |
| Profit Margin | 4.4% | 23.5% |
Balance Sheet & Liquidity Metrics
| Metric | LACTOSE (2025) | DIVISLAB (2025) |
|---|---|---|
| Cash & Equivalents | 44.81M | 4.15B |
| Total Current Assets | 573.26M | 100.81B |
| Total Current Assets % of Revenue | 49.3% | 108.1% |
| Total Current Liabilities | 448.90M | 14.52B |
| Total Current Liabilities % of Revenue | 38.6% | 15.6% |
| Long-Term Debt | 259.33M | 20.00M |
| Long-Term Debt % of Revenue | 22.3% | 0.0% |
| Total Shareholders Equity | 587.40M | 149.69B |
| Retained Earnings | 260.03M | 134.00B |
| Retained Earnings % of Revenue | 22.4% | 143.7% |
| Property, Plant & Equipment | 12.74M | 3.19B |
Cash Flow Statement Comparison
| Metric | LACTOSE (2025) | DIVISLAB (2025) |
|---|---|---|
| Operating Cash Flow | -49.12M | 19.67B |
| Operating Cash Flow % of Revenue | -4.2% | 21.1% |
| Capital Expenditures | -139.17M | -14.38B |
| Free Cash Flow | -146.70M | 2.15B |
| FCF Margin | -12.6% | 2.3% |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | LACTOSE | DIVISLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 12.59M | 265.47M |
| Float Shares | 5.19M | 117.72M |
| % Held by Insiders | 58.73% | 52.04% |
| % Held by Institutions | 0.00% | 28.65% |
| % Held by Public | 41.27% | 19.31% |
Dividend Analysis & Yield Comparison: Lactose India Ltd. vs Divi's Laboratories Ltd.
| Metric | LACTOSE | DIVISLAB |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹60.00 |
| Last 12-Month Dividend Yield | N/A | 0.91% |
| 3-Year Avg Annual Dividend | N/A | ₹50.00 |
| 3-Year Avg Dividend Yield | N/A | 0.70% |
| 3-Year Total Dividends | N/A | ₹150.00 |
| Ex-Dividend Date | N/A | Jul 25, 2025 |